Skip to main content
. 2018 Apr 11;146(7):920–930. doi: 10.1017/S0950268818000766

Table 3.

Number and percentage of HIV and hepatitis coinfections among persons living with diagnosed HIV infection and among persons with hepatitis infection, 15 US states and two cities

Jurisdiction Among persons living with diagnosed HIV infection, 2014a Among cumulative HBV cases through 2014b Among cumulative HCV cases through 2014b
Living HIV % HIV/HBV % HIV/HCV Cum HBV % HIV/HBV Cum HCV % HIV/HCV
State
Arizona 16 664 3.8 7.9 18 904 5.5 108 608 2.1
Connecticut 10 478 0.1 9.3 339 4.7 30 325 4.9
Florida 110 145 2.1 4.6 25 317 10.9 137 172 4.4
Iowa 2496 3.4 0 3122 4.1 1118 0.2
Louisiana 20 231 1.8 2.1 5467 8.4 17 634 3.2
Maryland 35 000 2.9 9.8 14 989 8.8 51 305 8.5
Massachusetts 21 243 1.6 7.4 15 190 2.6 67 767 2.8
Michigan 15 257 4.0 5.6 17 033 5.6 81 289 1.7
Minnesota 8140 4.5 6.6 23 340 3.0 41 198 2.7
North Dakota 353 3.7 7.4 660 2.7 7669 0.7
South Carolina 18 238 3.0 7.4 6822 12.2 40 374 5.1
Texasc 79 733 0.3 7.7 4472 6.7 211 117 3.8
Virginia 24 631 2.0 4.8 13 151 4.9 54 307 3.1
Washington 12 805 2.7 8.1 16 839 3.1 78 988 2.2
Wisconsin 6677 2.3 8.7 4391 4.8 42 846 2.2
City
New York City 108 723 2.3 7.3 89 717 3.9 101 980 10.9
San Francisco 13 584 1.3 11.3 10 131 3.3 19 353 13.3
Total 504 398 2.0 6.7 269 884 5.2 1 093 050 4.3

Cum, cumulative; HBV, hepatitis B virus (acute or chronic); HCV, hepatitis C virus (acute or chronic); HIV, human immunodeficiency virus.

a

Includes persons living with diagnosed HIV infection, regardless of stage at disease diagnosis, whose most recently known address through 31 December 2014, was within the jurisdiction and who were presumed to be alive as of 31 December 2014. Coinfections refer to persons living with diagnosed HIV infection matched with a hepatitis infection event occurring through 31 December 2014.

b

Includes persons reported with the hepatitis infection (acute or chronic) from the earliest event date included in the analysis for each jurisdiction (see Table 1) through 31 December 2014. Coinfections refer to persons reported with the hepatitis infection event date through 31 December 2014, matched with an HIV infection diagnosis through 31 December 2014.

c
Houston, Texas (USA), independently reported to CDC the following coinfection information for this project:
  1. Among 23 272 persons living with diagnosed HIV in Houston, 396 (1.7%) were coinfected with HBV and 1126 were coinfected with HCV (4.8%).
  2. Among the 7884 cumulative persons with HBV in Houston, 573 (7.3%) were coinfected with HIV.
  3. Among the 27 769 cumulative persons with HCV in Houston, 1722 (6.2%) were coinfected with HIV.
  4. Variation in coinfection data is caused by differences in the hepatitis information reported to the Houston Health Department and the Texas Department of State Health Services. Houston HBV data include acute and chronic conditions, but Texas HBV data include only acute conditions.